SCHEMBL23712243

SCHEMBL23712243

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4[nH]c5ccc(-c6ccc(-c7ccccn7)nc6)cc5c4c3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 4/20 0.49
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CHEK1 O14757 1/20 0.40
KDM4E B2RXH2 3/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
PKM P14618 2/20 0.40
KMT2A Q03164 1/20 0.40
PIM1 P11309 2/20 0.39
NPY5R Q15761 1/20 0.39
GABRA1 P14867 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRA6 Q16445 2/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20010293 0.99 HPGDS (0.48) HPGDSRAB9ANPC1SMN1; SMN2CHEK1
SCHEMBL20009966 0.93 HPGDS (0.46) HPGDSRAB9ANPC1SMN1; SMN2CHEK1
SCHEMBL20009981 0.91 HPGDS (0.45) HPGDSRAB9ANPC1SMN1; SMN2CHEK1
SCHEMBL20009872 0.86 MKNK1 (0.45) HPGDSMAPTKMT2AGABRA1GABRG2
SCHEMBL21540258 0.86 HPGDS (0.46) HPGDSRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL20009938 0.85 MKNK1 (0.47) HPGDSMAPTGABRA1GABRG2GABRB3
SCHEMBL20009871 0.85 TLR8 (0.47) HPGDSCHEK1MAPTPIM1PIM2
SCHEMBL20010063 0.85 HPGDS (0.50) HPGDSRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL20010159 0.85 HPGDS (0.50) HPGDSRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL20010245 0.85 HPGDS (0.43) HPGDSRAB9ANPC1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320261-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2021-10-14 US disclosed
US-11081648-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320261-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, AOX1 HPGDS 4354/4885RAB9A 3808/4885NPC1 1283/4885
US-11081648-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD1, OCIAD2, AOX1 HPGDS 4477/4885RAB9A 3547/4885NPC1 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.